340B Drug Pricing Program
On behalf of our members — including safety-net hospitals serving rural and underserved communities — we are pleased with today’s decision. The court’s decision halts a rule that would have caused a devastating sea change in a 30-year-old program relied upon by hospitals that serve America’s most…
The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin - December 16, 2025.
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
This webinar reviews key provisions proposed in the Outpatient, Ambulatory Surgical Center Final Rule for CY 2026. Some of the topics discussed include OPPS payment update and area wage index, Payment policies for drugs, biologicals and radiopharmaceuticals, Site-neutral payments, Behavioral health…
AHA 340B Advocacy Alliance - December 2, 2025.
AHA 340B Advocacy Alliance for December 1, 2025.
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District Court for the District of Maine to challenge the 340B Rebate Model Pilot Program.
Today, the American Hospital Association (AHA), the Maine Hospital Association (MHA) and four safety-net health systems from across the country filed a lawsuit in the United States District Court for the District of Maine to stop unlawful changes to a critical program that provides lower-cost drugs…